All
Celebrating A ‘Cancerversary’ In A COVID-19 World
January 16th 2021It’s okay for me to not feel like celebrating my 5-year cancerversary in a world that is upside down and backward because of COVID-19. Yes, I’m grateful and blessed, but I’m not bullet-proof. I’m human. I don’t have to feel guilty. None of us do.
Alleviating Pandemic-Related Anxiety Over Returning to the Clinic for Clinical Trials
January 16th 2021In an interview with CURE®, expert Martha Raymond explains the importance of clinical trials during the COVID-19 pandemic and how clinicians must find a way to help ease patients anxieties as they return to the clinic.
Areas Patients with CLL Can Focus On to Maintain Their Health Beyond Treatment
January 15th 2021In a recent interview with CURE®, a medical oncologist from the Dana-Farber Cancer Institute discussed why it’s important for patients with CLL, regardless of their treatment plans, to keep up on vaccinations and maintain a regular cancer screening schedule.
Enhertu Receives FDA Approval for Gastroesophageal, Gastric Cancer Subset
January 15th 2021The Food and Drug Administration approved Enhertu to treat adults with locally advanced or metastatic HER2-positive gastroesophageal or gastric cancer who have previously received a trastuzumab-based treatment regimen.
Savoring Every Ounce of Life While Undergoing Treatment for Skin Cancer
January 14th 2021In this episode of the “CURE Talks Cancer” podcast, we spoke with someone who has undergone 41 surgeries and physically debilitating treatments during his more than 15-year journey with several cases of skin cancer. We discussed his cancer journey, and why, as he starts a new treatment after his most prior therapy failed, he’s focused on quality rather than quantity of life.
Novel Drug with Dexamethasone Safe in Heavily Pretreated Multiple Myeloma
January 13th 2021Melflufen with dexamethasone was an effective treatment option for patients with relapsed or refractory multiple myeloma previously treated with a specific chemotherapy drug and/or an anti-CD38 monoclonal antibody.
Men with Prostate Cancer Experience Higher Levels of Fatigue Due to Inflammation
January 13th 2021Men who are receiving androgen deprivation therapy treatment for prostate cancer experience higher levels of fatigue and depression when compared to men who are not receiving treatment and who have no history of cancer.
Lessons from COVID-19: How to Support those Facing Serious Health Challenges Like Cancer
January 12th 2021In the wake of the COVID-19 pandemic, many of the serious medical difficulties patients with cancer face has been brought to the forefront for healthcare as a whole. But we can learn lessons from these challenges and find a stronger path forward.